Evidence-Based Deprescribing of Psychotropic Medications

EMPHN invites General Practitioners to an exclusive in-person event featuring Dr Mark Horowitz, a leading authority on deprescribing psychotropic medications.

Dr Horowitz will share evidence-based insights from the Maudsley Deprescribing Guidelines, focusing on:

• A structured framework for the safe and effective deprescribing of medications, including antidepressants and benzodiazepines.
• Practical strategies to support patients during tapering.
• Ensuring safe and effective deprescribing practices.

Followed by a panel discussion which will provide valuable insights into consumer and clinical issues around deprescribing. The panel will explore what best-practice clinical support could look like.

Supported by Reconnexion, this event offers a invaluable opportunity to deepen your understanding of deprescribing practices and learn how to implement these guidelines in your clinical practice.

Event suitable for General Practitioners and Health Professionals.